World's Best Scientists 2026 revealed!
Shinichi Oka

Shinichi Oka

D-Index & Metrics

Immunology

D-Index
62
Citations
20426
World Ranking
3097
National Ranking
128

Overview

Shinichi Oka is affiliated with Kumamoto University in Japan and has contributed extensively to research in the fields of Medicine, Immunology, and Microbiology. Their work primarily focuses on Infectious Diseases, Epidemiology, and Virology, with a significant emphasis on HIV research and treatment.

The scientist's research topics cover a range of areas related to HIV/AIDS, including HIV Research and Treatment, HIV/AIDS Research and Interventions, and HIV/AIDS drug development and treatment. Other notable topics within their scope include HIV-related health complications and treatments, HIV, Drug Use, Sexual Risk, Immune Cell Function and Interaction, and Hepatitis C virus research.

Shinichi Oka has collaborated frequently with several co-authors, highlighting strong professional partnerships. These co-authors include Hiroyuki Gatanaga, Daisuke Mizushima, Misao Takano, Yoshimi Kikuchi, and Kôji Watanabe.

Their publication record spans a variety of journals and venues, notably:

  • Global Health & Medicine (22 publications)
  • Scientific Reports (9 publications)
  • Journal of Infection and Chemotherapy (7 publications)
  • Journal of Virology (7 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (5 publications)

Noteworthy papers authored include:

  • "Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection," 2020, New England Journal of Medicine
  • "Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study," 2022, Gastroenterology
  • "Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study," 2021, The Lancet HIV
  • "Population-level Metagenomics Uncovers Distinct Effects of Multiple Medications on the Human Gut Microbiome," 2022, Gastroenterology
  • "Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials," 2020, JAIDS Journal of Acquired Immune Deficiency Syndromes

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

    Paul E Sax;David Wohl;Michael T Yin;Frank Post

  • Adaptation of HIV-1 to human leukocyte antigen class I

    Y. Kawashima;K. Pfafferott;J. Frater;P. Matthews

  • Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

    Chloe Orkin;Keikawus Arasteh;Miguel Górgolas Hernández-Mora;Vadim Pokrovsky

  • Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

    Kiyoto Tsuchiya;Hiroyuki Gatanaga;Natsuo Tachikawa;Katsuji Teruya

  • Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26

    Hiroyuki Gatanaga;Tsunefusa Hayashida;Kiyoto Tsuchiya;Munehiro Yoshino

  • Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

    Andrea Antinori;Gabriele Arendt;Igor Grant

  • Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.

    Kazumoto Murata;Mai Asano;Akihiro Matsumoto;Masaya Sugiyama

  • HLA-Cw8 primarily associated with hypersensitivity to nevirapine.

    Hiroyuki Gatanaga;Hirohisa Yazaki;Junko Tanuma;Miwako Honda

  • Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.

    Dorita Avila;Keri N. Althoff;Catrina Mugglin;Kara Wools-Kaloustian

  • Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study

    Chloe Orkin;Shinichi Oka;Patrick Philibert;Cynthia Brinson

  • Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection.

    Setsuko Ida;Natsuo Tachikawa;Aya Nakajima;Manabu Daikoku

  • Functional Expression of the Chemokine Receptor CCR5 on Virus Epitope-Specific Memory and Effector CD8+ T Cells

    Katsuhiko Fukada;Yuji Sobao;Hiroko Tomiyama;Shinichi Oka

  • Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1.

    Yuki Ikeda-Moore;Hiroko Tomiyama;Kiyoshi Miwa;Shinichi Oka

  • Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection

    Beatrice Ondondo;Hayato Murakoshi;Genevieve Clutton;Genevieve Clutton;Sultan Abdul-Jawad

  • Extensive gut virome variation and its associations with host and environmental factors in a population-level cohort

    Unknown

  • Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients

    Takeshi Nishijima;Hirokazu Komatsu;Hiroyuki Gatanaga;Takahiro Aoki

  • Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.

    Hiroyuki Gatanaga;Natsuo Tachikawa;Yoshimi Kikuchi;Katsuji Teruya

  • Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.

    Giuliano Rizzardini;Edgar T. Overton;Chloe Orkin;Susan Swindells

  • Serum (1→3) β-D-Glucan as a Noninvasive Adjunct Marker for the Diagnosis of Pneumocystis Pneumonia in Patients with AIDS

    Tamayo Watanabe;Akira Yasuoka;Junko Tanuma;Hirohisa Yazaki

  • Polymorphism in the Interleukin-4 Promoter Affects Acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype

    Emi E. Nakayama;Yoshihiko Hoshino;Xiaomi Xin;Huanliang Liu

  • Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5).

    Atsuko Hachiya;Saori Aizawa-Matsuoka;Mari Tanaka;Yukiko Takahashi

  • Novel Mutation of Human DNA Polymerase γ Associated with Mitochondrial Toxicity Induced by Anti-HIV Treatment

    Hikaru Yamanaka;Hiroyuki Gatanaga;Pope Kosalaraksa;Saori Matsuoka-Aizawa

Frequent Co-Authors

Hiroyuki Gatanaga
Hiroyuki Gatanaga Kumamoto University
Satoshi Kimura
Satoshi Kimura University of Tokyo
Masafumi Takiguchi
Masafumi Takiguchi Kumamoto University
Matthew Law
Matthew Law University of New South Wales
Adeeba Kamarulzaman
Adeeba Kamarulzaman University of Malaya
Aikichi Iwamoto
Aikichi Iwamoto Japan Agency for Medical Research and Development
Hiroaki Mitsuya
Hiroaki Mitsuya Kumamoto University
Zabrina L. Brumme
Zabrina L. Brumme Simon Fraser University
Thira Sirisanthana
Thira Sirisanthana Chiang Mai University
Manabu Mochizuki
Manabu Mochizuki Tokyo Medical and Dental University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, related healthcare fields offer diverse career pathways with varying entry requirements. Many aspiring healthcare professionals start with programs that are accessible and accommodating to different educational backgrounds. If you’re exploring nursing, you might want to consider which LPN programs are easiest to get into. These programs can provide a solid foundation in patient care and clinical skills.

Advanced practice roles, such as nurse practitioners, also present opportunities to specialize clinically. When researching options, finding nurse practitioner programs with easy admission can make further education more attainable for many students balancing other commitments.

Mental health is an increasingly important area within immunology-related care, and online options are growing. For those focused on psychiatric nursing, programs with high clinical placement success are crucial. You can explore top options by looking into PMHNP programs online with best clinical placement.

Cost is another critical factor. Affordable programs help reduce barriers to entry, especially for specialized fields. To identify budget-friendly choices in psychiatric nursing, consider researching cheap psych NP programs that maintain quality education and clinical training.

Best Scientists Citing Shinichi Oka

Trending Scientists

Recently Published Articles